Consumer telehealth · Weight-care / GLP-1
GobyMeds
GobyMeds is a cash-pay consumer telehealth brand for compounded GLP-1 weight care and related wellness medications with published starter pricing. It is not a hospital or insurance-billed obesity clinic network.
Strong fit
- Adults paying cash who compare low posted monthly prices for compounded GLP-1 starter bundles
- Patients who want clear prices with no membership and a checkout that takes HSA or FSA cards
- People comparing budget consumer weight-loss brands such as Eden and Found
Weak fit
- Patients who need obesity care billed to insurance, with long-term coaching
- People who only want FDA-approved brand-name GLP-1s and no compounded options
- People who want a large national brand with a lot of published research on results
Bottom line
GobyMeds is worth considering for budget-minded adults who want compounded GLP-1 weight medication with clear published prices and simple online intake. It suits people for whom price is the deciding factor. People who want deeper clinical follow-up should look at Eden, Fridays, or Found.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
GobyMeds is a cash-pay consumer telehealth brand based in Delaware and led by founder and CEO Justin McCombs. It says it has more than 75,000 patients.
It sells compounded semaglutide and tirzepatide bundles and related wellness medications, with posted starter prices, an online sign-up, and home delivery. It is a consumer product, not a hospital.
Its clear cash prices are the main draw. Clinician quality, partner pharmacies, and long-term follow-up still vary by case and should be checked.
It also has less public evidence of its size than Found or Eden.
Among weight care companies we review, GobyMeds scores lowest. It is a budget option for people who care most about posted prices and a simple sign-up.
Eden and Fridays suit people who want a broader program led by clinicians. Found suits people who want coaching with their care, and Henry Meds is the closest comparison among compounded weight-loss services.
Its prices are clear, but its follow-up and clinical evidence are thinner.
Competitor landscape
| Vendor | Overall | Ease of use |
|---|---|---|
| Form Health | 7.5 | 7.3 |
| Found | 7.4 | 7.2 |
| Calibrate | 7.3 | 7.1 |
| Eden | 7.3 | 7.2 |
| Fridays | 7.1 | 7.0 |
| Mochi Health | 7.0 | 6.6 |
| Nu Image Medical | 6.8 | 6.5 |
| Sesame | 6.8 | 6.7 |
| Henry Meds | 6.7 | 6.3 |
| GobyMeds | 6.6 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | Cash-pay bundles of compounded GLP-1s and related wellness medications, with posted starter prices. Its website does not mention a membership fee. |
| What usually drives cost | The drug (semaglutide or tirzepatide), how many months the bundle covers, the dose, and add-ons such as NAD+ or sermorelin. |
| What to ask before you buy | The full cost of your first three months, including clinician review, medication, and shipping. |
| Published pricing | Compounded semaglutide starter bundles are advertised from about $99/month. Tirzepatide costs more. Confirm the price at checkout. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get GobyMeds to function | |
| An honest health and medication history for the clinician to review | Incomplete answers delay or block a prescription. |
| A clear budget for paying cash for medication and visits | Unexpected totals make people quit. |
| A plan to learn injections, or an oral option if one is offered | Patients who are not ready stall once the medication arrives. |
| A confirmed shipping address and a way to keep the medication cold | A failed delivery wastes medication. |
| A follow-up schedule you will keep | A single fill without check-ins gives weaker results. |
| What will maximize your value | |
| Finish labs or required screening before raising the dose | Skipping these steps raises safety risk. |
| Track weight, side effects, and missed doses every week for 90 days | Opening the app is not a result. |
| Use one pharmacy, and avoid getting prescriptions from two telehealth services | Two sources make dosing confusing. |
| Message the care team early about nausea or supply gaps | Side effects you do not report make people quit. |
| Check the price at each refill before autopay charges you | Dose changes change the monthly cost. |
| Deal-breakers | |
| You need obesity care covered by insurance and will not pay cash. | |
| A clinician decides a GLP-1 is not right for you. | |
| You cannot safely receive or refrigerate medication. | |
| You will not do the required follow-up or screening. | |
| You expect a consumer telehealth brand to arrange hospital procedures. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Sign-up | 1-7 days. Answer the quiz and health history, and check eligibility. |
| 2 | Clinician review | 1-7 days. Approval, or other options. |
| 3 | First shipment | 2-10 days. The pharmacy fills and delivers the order. |
| 4 | Dose changes and follow-up | 1-6 months. Adjust the dose and check in. |
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.